tiprankstipranks
Advertisement
Advertisement
Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction
PremiumThe FlyGyre Therapeutics to acquire Cullgen in $300M all-stock transaction
4M ago
Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction
Premium
The Fly
Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction
4M ago
Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction
Premium
The Fly
Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction
4M ago
Pulmatrix reports Q3 EPS (24c) vs. (71c) last year
PremiumThe FlyPulmatrix reports Q3 EPS (24c) vs. (71c) last year
8M ago
Pulmatrix to potentially divest its patent portfolio for iSPERSE technology
Premium
The Fly
Pulmatrix to potentially divest its patent portfolio for iSPERSE technology
8M ago
Pulmatrix Reports Q2 2025 Results and Merger Plans
Premium
Company Announcements
Pulmatrix Reports Q2 2025 Results and Merger Plans
10M ago
Pulmatrix trading resumes
PremiumThe FlyPulmatrix trading resumes
12M ago
Pulmatrix Stockholders Approve Merger with Cullgen
Premium
Company Announcements
Pulmatrix Stockholders Approve Merger with Cullgen
1y ago
Pulmatrix Reports 2024 Financials and Merger Plans
Premium
Company Announcements
Pulmatrix Reports 2024 Financials and Merger Plans
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100